Application of High Molecular Hydrogel in The Treatment of Myocardial Infarction

Authors

  • Chuhao Sun

DOI:

https://doi.org/10.54097/z9y86646

Keywords:

High molecular hydrogel, Myocardial infarction, medical engineering.

Abstract

Myocardial infarction (MI) is the world's leading disabling and fatal disease. Currently, clinical treatment methods mainly include drug therapy, angioplasty, and coronary artery bypass grafting. These traditional treatment methods are difficult to repair damaged myocardial tissue and cannot restore normal necrotic and fibrotic myocardium. Therefore, it is imperative to improve the efficacy of traditional treatment methods and find new treatment strategies. More and more studies have found that stem cell transplantation can repair damaged myocardium, but stem cells transplanted to the affected site undergo oxidative damage, compression loss, and low cell survival and retention rates. At present, there is an urgent need to seek new methods that can effectively repair damaged myocardium and restore cardiac function. In recent years, with the development of regenerative medicine engineering and the continuous optimization of polymer technology and the development of new biomaterials, it has become a reality to create lost or functionally damaged tissues and organs through theoretical methods of biology and engineering, enabling them to have the structure and function of normal tissues and organs. This article will focus on the latest progress in methods for repairing damaged myocardium in myocardial infarction through polymer hydrogel materials.

Downloads

Download data is not yet available.

References

Shao L, Liu M, Qiu J, et al. Preparation of Conductive Hydrogel [J]. Progress in Chemistry, 2011, 23 (5).

Leonardo S, Maurizio F, Silvia P, et al.A Review of the Molecular Mechanisms Underlying the Development and Progression of Cardiac Remodeling [J]. Oxidative Medicine and Cellular Longevity, 2017, (2017-7-2), 2017, 2017: 1 - 16.

Shinde A V, Frangogiannis N G. Fibroblasts in myocardial infarction: A role in inflammation and repair [J]. Journal of Molecular & Cellular Cardiology, 2014, 70: 74 - 82. DOI: 10.1016/j.yjmcc.2013. 11. 015.

Prabhu, Sumanth, D, et al. The Biological Basis for Cardiac Repair After Myocardial Infarction from Inflammation to Fibrosi s [J]. Circulation research: a journal of the American Heart Association, 2016, 119 (1): 91 - 112.

Lijnen P. Induction of cardiac fibrosis by transforming growth factor-beta (1). [J]. Molecular Genetics & Metabolism, 2000, 71.

Van d B S W M, Diez J, Blankesteijn W M, et al. Myocardial remodeling after infarction: the role of myofibroblasts. [J]. Nature Reviews Cardiology, 2010, 7 (1): 30.

Kong P, Christia P, Frangipanni’s N G. The pathogenesis of cardiac fibrosis [J]. Cellular Molecular Life Sciences, 2014.

Seccia T M, Rigato M, Ravarotto V. ROCK (RhoA/Rho Kinase) in Cardiovascular-Renal Pathophysiology: A Review of New Advancements [J]. Journal of Clinical Medicine, 2020, 9 (5).

Llevadot J, Giugliano R P, Antman E M. Bolus fibrinolytic therapy in acute myocardial infarction. [J]. JAMA: the Journal of the American Medical Association, 2001 (4): 286.

Werf F V D, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation [J]. Eur Heart J, 2003.

Sharp T E, Schena G J, Hoachlandr-Hobby A R, et al. Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction [J]. Circulation Research, 2017: CIRCRESAHA. 117. 311174.

Shi C, Zhao Y, Yang Y, et al. Collagen-binding VEGF targeting the cardiac extracellular matrix promotes recovery in porcine chronic myocardial infarction [J]. Biomater, 2017: 10. 1039.

Bozolan B K, Duman O, Tun S. Preparation and characterization of thermosensitive chitosan/carboxymethylcellulose/scleroglucan nanocomposite hydrogels [J]. International Journal of Biological Macromolecules, 2020, 162.

Rodness J, Mihic A, Miyagi Y, et al. VEGF-loaded microsphere patch for local protein delivery to the ischemic heart [J]. Acta Biomaterialia, 2016.

Gao, LingKupfer, Molly E.Jung, Jangwook P. Yang, LibangZhang, PatrickSie, Yong DaQuyen TranAjeti, Visa Freeman, Brian T. Fast, Vladimir G. Campagnola, Paul J. Ogle, Brenda M. Zhang, Jianyi. Myocardial Tissue Engineering with Cells Derived from Human-Induced Pluripotent Stem Cells and a Native-Like, High-Resolution, 3-Dimensionally Printed Scaffold [J]. Circulation research: a journal of the American Heart Association, 2017, 120 (8).

A C C H, C H W T B, A W Y L, et al. A translational approach in using cell sheet fragments of autologous bone marrow-derived mesenchymal stem cells for cellular cardiomyopathy in a porcine model – ScienceDirect [J]. Biomaterials, 2013, 34 (19): 4582 - 4591.

Li J, Shu Y, Hao T, et al. A chitosan–glutathione based injectable hydrogel for suppression of oxidative stress damage in cardiomyocytes [J]. Biomaterials, 2013, 34 (36): 9071 - 9081.

Dewavrin, Jean-Yves, Bhakoo, et al. Microcapsules engineered to support mesenchymal stem cell (MSC) survival and proliferation enable long-term retention of MSCs in infarcted myocardium [J]. Biomaterials, 2015.

Downloads

Published

29-12-2023

How to Cite

Sun, C. (2023). Application of High Molecular Hydrogel in The Treatment of Myocardial Infarction. Highlights in Science, Engineering and Technology, 74, 1779-1785. https://doi.org/10.54097/z9y86646